← All Syros Pharmaceuticals, INC filings

Syros Pharmaceuticals, INC Form 4 insider transactions

OTC.Pink
SYRS
Syros Pharmaceuticals, INC
Form 4: Syros Pharmaceuticals Executive Kristin Stephens Reports Stock Transactions
Kristin Stephens, Chief Development Officer of Syros Pharmaceuticals, reports the acquisition and disposal of common stock and restricted stock units.
OTC.Pink
SYRS
Syros Pharmaceuticals, INC
Form 4: Syros Pharmaceuticals Director Nancy A. Simonian Reports Stock Transactions
Director Nancy A. Simonian reported the vesting of restricted stock units and subsequent tax withholding, resulting in changes to her beneficial ownership of Syros Pharmaceuticals stock.
OTC.Pink
SYRS
Syros Pharmaceuticals, INC
Form 4: Syros Pharmaceuticals' Chief Medical Officer Reports Stock Transactions
Chief Medical Officer of Syros Pharmaceuticals, David Roth, reports acquisition and disposal of common stock and restricted stock units.
OTC.Pink
SYRS
Syros Pharmaceuticals, INC
Form 4: Syros Pharmaceuticals Executive Gerald Quirk Reports Stock Transactions
Gerald Quirk, Chief Legal & Compliance Officer of Syros Pharmaceuticals, reports the vesting of restricted stock units and subsequent tax withholding.
OTC.Pink
SYRS
Syros Pharmaceuticals, INC
Form 4: Syros Pharmaceuticals CFO Jason Haas Reports Stock Transactions
Jason Haas, CFO of Syros Pharmaceuticals, reports the acquisition and disposal of common stock and restricted stock units related to vesting.
OTC.Pink
SYRS
Syros Pharmaceuticals, INC
Form 4: Syros Pharmaceuticals CEO Conley Chee Reports Stock Transactions
CEO Conley Chee reports acquisition and disposal of Syros Pharmaceuticals (SYRS) common stock and restricted stock units.